Literature DB >> 10559937

Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response.

G S Ashcroft1, X Yang, A B Glick, M Weinstein, J L Letterio, D E Mizel, M Anzano, T Greenwell-Wild, S M Wahl, C Deng, A B Roberts.   

Abstract

The generation of animals lacking SMAD proteins, which transduce signals from transforming growth factor-beta (TGF-beta), has made it possible to explore the contribution of the SMAD proteins to TGF-beta activity in vivo. Here we report that, in contrast to predictions made on the basis of the ability of exogenous TGF-beta to improve wound healing, Smad3-null (Smad3ex8/ex8) mice paradoxically show accelerated cutaneous wound healing compared with wild-type mice, characterized by an increased rate of re-epithelialization and significantly reduced local infiltration of monocytes. Smad3ex8/ex8 keratinocytes show altered patterns of growth and migration, and Smad3ex8/ex8 monocytes exhibit a selectively blunted chemotactic response to TGF-beta. These data are, to our knowledge, the first to implicate Smad3 in specific pathways of tissue repair and in the modulation of keratinocyte and monocyte function in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559937     DOI: 10.1038/12971

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  265 in total

Review 1.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

2.  Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development.

Authors:  M Weinstein; S P Monga; Y Liu; S G Brodie; Y Tang; C Li; L Mishra; C X Deng
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 3.  SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury.

Authors:  A D Bradshaw; E H Sage
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

4.  Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.

Authors:  S J Wicks; S Lui; N Abdel-Wahab; R M Mason; A Chantry
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

5.  Interference with transforming growth factor-beta/ Smad3 signaling results in accelerated healing of wounds in previously irradiated skin.

Authors:  Kathleen C Flanders; Christopher D Major; Alidad Arabshahi; Ekinadese E Aburime; Miya H Okada; Makiko Fujii; Timothy D Blalock; Gregory S Schultz; Anastasia Sowers; Mario A Anzano; James B Mitchell; Angelo Russo; Anita B Roberts
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 6.  Fibrotic disease and the T(H)1/T(H)2 paradigm.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

Review 7.  Skin wound healing modulation by macrophages.

Authors:  Mathieu P Rodero; Kiarash Khosrotehrani
Journal:  Int J Clin Exp Pathol       Date:  2010-07-25

8.  Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25.

Authors:  Lisa G Gregory; Sara A Mathie; Simone A Walker; Sophie Pegorier; Carla P Jones; Clare M Lloyd
Journal:  Am J Respir Crit Care Med       Date:  2010-03-25       Impact factor: 21.405

9.  Smad4 disruption accelerates keratinocyte reepithelialization in murine cutaneous wound repair.

Authors:  Leilei Yang; Wenlong Li; Shaoxia Wang; Lijuan Wang; Yang Li; Xiao Yang; Ruiyun Peng
Journal:  Histochem Cell Biol       Date:  2012-05-30       Impact factor: 4.304

10.  Eosinophilic Esophagitis-Associated Chemical and Mechanical Microenvironment Shapes Esophageal Fibroblast Behavior.

Authors:  Amanda B Muir; Kara Dods; Steven J Henry; Alain J Benitez; Dale Lee; Kelly A Whelan; Maureen DeMarshall; Daniel A Hammer; Gary Falk; Rebecca G Wells; Jonathan Spergel; Hiroshi Nakagawa; Mei-Lun Wang
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-08       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.